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To the Editor – we wish to comment on the article by Lee et al 1. We 
welcome this important work emphasising the spread of pathogenic multidrug 
resistance Staphylococcus epidermidis globally but wish to highlight some critical 
findings derived from the deposited genomic data which have been partially reported 
in the supplementary information (Supplementary Table 1, sheet D) but not 
discussed in the article.  
The study by Lee et al supports the concerns raised in numerous smaller scale and 
local studies that S. epidermidis is a dominant reservoir of multidrug resistance 
genes 2. The authors’ main focus is the prevalence of rpoB associated with 
resistance to rifampicin widely used in medical devices. We wish to draw the 
readers’ attention to the high carriage of biocide resistance genes as well as heavy 
metal resistance in association with staphylococcal cassette chromosome mec 
(SCCmec) elements in hospital-adapted multidrug resistant S. epidermidis. 
Biocide resistance. We focussed our analyses on i) qacA/B encoding an 
efflux pump for a variety of lipophilic cations and strongly associated with reduced 
microbial susceptibility to chlorhexidine 3, ii) the plasmid-borne ileS2 gene and the 
core-genome V588F mutation in IleS responsible for high- and low-level mupirocin 
resistance, respectively 4. Chlorhexidine is one of the most commonly used biocides 
in the community as well as hospital decontamination and infection control, with 
applications ranging from mouthwashes to impregnated catheters and skin/mucosal 
surface decontamination in intensive care units. Equally mupirocin is widely 
employed for decontamination of nasal surfaces in intensive care. Whilst these 
measures have shown remarkable effectiveness in control of bloodstream infections 
including those related to MRSA, MSSA and coagulase-negative Staphylococci 5, 
resistance to mupirocin and declining susceptibility to chlorhexidine has been 
reported worldwide 3, 6. Resistance to biocides has raised concerns of selection of 
multidrug resistant bacteria associated with hospital-acquired infections with a most 
alarming report suggesting that exposure to chlorhexidine is associated with 
resistance to last resort antibiotic colistin 7.  
The prevalence of qacA/B in S. aureus reported over the last decade is very 
variable although the drivers for high carriage are not clear. While some studies 
continue to report declining susceptibility to chlorhexidine and increasing prevalence 
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of qacA/B in MRSA from a range of clinical settings 8, 9, other studies, including our 
own work, report low presence of qacA/B in S. aureus from screening samples and 
bacteraemia patients 10, 11. However, we have shown a high prevalence (80%) of 
qacA/B in S. epidermidis isolates from blood cultures randomly collected over 6 
years in an intensive care unit in Scotland, with qacA/B carriage coinciding with 
reduced susceptibility to chlorhexidine 11. Importantly the majority of qacA/B isolates 
in this study belonged to multidrug resistant clone ST2, the same lineage that 
dominated in the collection of isolates studied by Lee et al. We have also identified 
genetic determinants of resistance to mupirocin (ileS2, V588F mutation in IleS) 
and/or triclosan (sh-fabI, F204L mutation in FabI) in 65% of qacA/B S. epidermidis 
isolates 11. Notably, in some cases mupirocin resistance genes were co-located with 
qacA/B on variants of known MRSA mobile elements raising the possibility of 
horizontal transfer of multidrug resistance genes between S. epidermidis and S. 
aureus 11.  
We have analysed the genomic data published by Lee et al (ENA, Bioproject 
PRJEB12090, PRJNA470534 and PRJNA470752) for carriage of the qacA/B genes, 
the IleS-V588F mutation, the ileS2(mupA) gene, the FabI-F204L mutation and the 
sh-fabI gene. We did not analyse either ileS or fabI promoter mutations, thus 
underestimating resistance to mupirocin and triclosan. Analysis of the 226 clinical 
isolates in Lee et al  revealed significant enrichment of biocide resistance in the three 
hospital-adapted multidrug resistant lineages of this global collection of pathogenic 
S. epidermidis, namely ST2, ST2-BPH0662 and ST23. The proportion of qacA/B 
positive isolates belonging to the ST2 and ST2-BPH0662 clones (85% and 78%, 
respectively) was significantly higher (p= 0.004, Fisher’s exact test) than that 
detected in all other isolates cumulatively (68%). The ST23 and the ST2-BPH0662 
lineage showed increased carriage of the core-genome IleS-V588F mupirocin 
resistance mutation compared to the other isolates (56% ST23, 48% ST2-BPH0662, 
10% in other isolates; p< 0.0001 for both lineages) but not of the plasmid-borne ileS2 
(mupA) gene. There were no significant differences in the carriage rate of sh_fabI 
and FabI-F204L mutations pointing to a lesser role of triclosan, a biocide primarily 
used in household products. 
4 
 
SCCmec and heavy metal resistance. Our analysis revealed that all isolates 
belonging to the ST2 BPH0662 lineage described in Lee et al carry an SCCmec 
element orthologous to the SCCmec associated with the copper and mercury 
resistance mobile element (COMER) in community-associated MRSA USA300 12. In 
ST2 BPH0662 it presents as a composite element comprising an SCCmec type III 
and a COMER-like locus which, in addition to copper and mercury resistance, carries 
cadmium and arsenic resistance gene clusters that are not present in the MRSA 
SCCmec COMER element. Of note, decreased susceptibility to copper has been 
recently linked to increased resistance of COMER-positive S. aureus to macrophage 
killing and the success of the USA300 clone 13.  
The global and sustained dominance of three hospital-adapted multidrug 
resistant lineages with high carriage of chlorhexidine and mupirocin resistance genes 
raises concerns of selection of multidrug resistance by these two biocides. Further, 
carriage of SCCmec in association with metal resistance genes points to selection of 
multidrug resistant S. epidermidis which may display enhanced fitness and 
resistance to innate immunity by analogy with S. aureus. Indeed, we have previously 
demonstrated that antibiotic use is an important predictor of prevalence density of 
dominant multidrug resistant clones 14 – we speculate a similar effect by intensive 
use of metals, chlorhexidine and mupirocin as previously suggested 15. To support or 
refute this claim we recommend that future genomic analysis of hospital-acquired 
multidrug resistant S. epidermidis should include analysis of biocide resistance 
genes. Functional studies are required to evaluate the role of heavy metal resistance 
genes related to SCCmec elements in S. epidermidis. 
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